Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from STE

Is STERIS Stock Underperforming the S&P 500?

STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.

Barchart

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

StockNews.com

3 Healthcare Innovators Transforming Patient Care

The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

STERIS Stock Outlook: Is Wall Street Bullish or Bearish?

STERIS has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s potential.

Barchart

STERIS’ Quarterly Earnings Preview: What You Need to Know

STERIS will unveil its Q1 earnings next month, and analysts project a single-digit bottom-line growth.

Barchart

3 Medical Equipment Stocks to Buy for a Healthy Portfolio

Increased chronic diseases, rising health awareness, and technological developments are poised to keep the medical equipment industry buoyed for the long term. Therefore, medical equipment stocks STERIS plc (STE), Embecta Corp. (EMBC), and Avanos Medical (AVNS), with noteworthy fundamentals, could be solid buys for a healthy portfolio. Read on….

StockNews.com

10 Biggest Price Target Changes For Thursday

Macquarie boosted the price target on Twilio Inc. (NYSE: TWLO) from $281 to $306. Twilio shares jumped 20.4% to $243.23 in pre-market trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance

Steris plc (NYSE: STE)

Benzinga

1 2

Organisations

Medical Devices Equipment

13 stories

EMBC

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

United States

388,619 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.